{"nct_id":"NCT05268068","title":"A Study of Intravenously (IV) Infused or Subcutaneously (SC) Injected Risankizumab in Healthy Adult Participants in China","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2019-06-27","start_date_type":"ACTUAL","primary_completion_date":"2020-04-26","primary_completion_date_type":"ACTUAL","completion_date":"2020-04-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}